Nina Shah, MD, on Clinical Implications of Novel Therapies for Multiple Myeloma

Posted: Wednesday, August 25, 2021

Nina Shah, MD, of the University of California, San Francisco, discusses new drug combinations for patients with multiple myeloma, who is eligible for such treatment, the way to administer the regimens, and how best to monitor response. Dr. Shah also compares the newer treatments with the standard of care in terms of durability over the long term.